<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00785109</url>
  </required_header>
  <id_info>
    <org_study_id>Vitamin K Study</org_study_id>
    <secondary_id>2008-005306-39</secondary_id>
    <nct_id>NCT00785109</nct_id>
  </id_info>
  <brief_title>Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification</brief_title>
  <acronym>08-002</acronym>
  <official_title>Vitamin K Containing Nutritional Supplement for Activation of Matrix-GIa-proteins (MGP) and Inhibition of Aortic Valve Calcification Process</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this mono-center,open,three-armes, controlled, randomized phase I study the progress of
      aortic valve calcification with and without vitamin K supplementation will be investgated.
      This will be done by means of measurements of concentrations from osteocalcine and MPG in
      blood serum, echocardiography, cardiac computed tomography and cardiac MRI
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be allocated to two groups with either

        1. additional intake of 2 mg vitamin k1 daily

        2. controll group without additional intake of Vitamin K

      Treatment group a will include 100 patients, the controll group should include 100 patients.
      None of all patients should require renal dialysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of aortic valve calcification by activation of the calcification inhibiting protein MGP by means of additional intake of vitamin K</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>progression of diastolic and systolic dysfunction in the three treatment groups</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Aortic Valve Calcification</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 patients daily additional intake of 2mg vitamin k1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 patients no additional intake of vitamin K</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin K supplementation</intervention_name>
    <description>Daily vitamin K supplementation per os (2 mg once a day)Experimental 1 Placebo Experimental 2</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aortic valve calcification,verified by echocardiography

        Exclusion Criteria:

          -  chronic or acute intestinal diseases

          -  terminal renal failure

          -  allergic reaction on soya containing products

          -  recent additional intake of vitamin K

          -  oral anticoagulation with vitamin K antagonists (Marcoumar)

          -  systemic therapy with corticosteroids

          -  anamnestic venous thrombosis (pelvet or legs)or embolization of lung arteria

          -  pregnant or breastfeeding women

          -  persons without mental ability or capacity to understand and follow the instructions
             of the investigator

          -  women of childbearing age without safe contraceptional devices

          -  minority
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Koos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine, Division of Cardiology, Pulmonology and Vascular Medicine</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2008</study_first_submitted>
  <study_first_submitted_qc>November 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2008</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aortic valve calcification</keyword>
  <keyword>vitamin K supplementation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcinosis</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin K</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

